These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 227597)

  • 21. Treatment of advanced adenocarcinoma of the lung with ftorafur, doxorubicin, cyclophosphamide, and cisplatin (FACP) and intensive iv hyperalimentation.
    Jordan WM; Valdivieso M; Frankmann C; Gillespie M; Issell BF; Bodey GP; Freireich EJ
    Cancer Treat Rep; 1981; 65(3-4):197-205. PubMed ID: 6786737
    [No Abstract]   [Full Text] [Related]  

  • 22. [Benefits of cisplatin-based polychemotherapy in non-small cell bronchogenic carcinoma. Kyushu Lung Cancer Chemotherapy Study Group].
    Ohta M; Hara N; Ichikawa Y; Kanda T; Shima K; Tamura K; Hokama M
    Gan To Kagaku Ryoho; 1988 Jun; 15(6):1901-8. PubMed ID: 2454615
    [TBL] [Abstract][Full Text] [Related]  

  • 23. cis-Dichlorodiammineplatinum(II), adriamycin, cyclophosphamide, CCNU, and vincristine in non-small cell lung carcinoma: a preliminary report.
    Takita H; Marabella PC; Edgerton F; Rizzo D
    Cancer Treat Rep; 1979 Jan; 63(1):29-33. PubMed ID: 369692
    [No Abstract]   [Full Text] [Related]  

  • 24. Lack of clinical therapeutic synergism between cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum(II) in metastatic human colorectal carcinoma.
    O'Connell MJ; Moertel CG; Rubin J; Schutt AJ; Creagan ET
    Cancer Treat Rep; 1980; 64(2-3):311-3. PubMed ID: 7190870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Chemotherapy for advanced gynecological carcinoma with cis-dichlorodiammineplatinum (II), adriamycin and/or cyclophosphamide after failure of initial treatment (author's transl)].
    Takizawa K; Matsuzawa M; Takahashi M; So E; Hasumi K; Sampi K
    Nihon Gan Chiryo Gakkai Shi; 1981 Oct; 16(6):1292-1302. PubMed ID: 7199554
    [No Abstract]   [Full Text] [Related]  

  • 26. Mitomycin C in advanced adenocarcinoma and large cell carcinoma of the lung.
    Samson MK; Comis RL; Baker LH; Ginsberg S; Fraile RJ; Crooke ST
    Cancer Treat Rep; 1978 Jan; 62(1):163-5. PubMed ID: 203393
    [No Abstract]   [Full Text] [Related]  

  • 27. Phase II trial of cis-dichlorodiammineplatinum(II) in advanced malignant lymphoma and small cell lung cancer: preliminary results.
    Cavalli F; Jungi WF; Sonntag RW; Nissen NI; Holland JF
    Cancer Treat Rep; 1979; 63(9-10):1599-603. PubMed ID: 227599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Four-drug combination chemotherapy in extensive non-small cell lung cancer: a Southwest Oncology Group Pilot Study.
    Livingston RB; Mira J; O'Bryan RM
    Cancer Treat Rep; 1981; 65(1-2):143-4. PubMed ID: 6164484
    [No Abstract]   [Full Text] [Related]  

  • 29. [Combination chemotherapy including cisplatin in lung cancer by bronchial artery infusion].
    Miyake M; Hiraki Y; Douke T; Kashitani N; Kondou S; Kimoto S; Hashimoto K; Aono K; Tanaka N; Inoue F
    Rinsho Hoshasen; 1988 Jan; 33(1):35-40. PubMed ID: 2452907
    [No Abstract]   [Full Text] [Related]  

  • 30. [Combination chemotherapy with cis-platinum, adriamycin and mitomycin C (PAM) in the treatment of non-small cell carcinoma of the lung].
    Nakano H; Kurihara M; Saito R; Takise A; Tsuchiya S; Minato K; Takehara K; Saruya T; Kuwabara H; Fueki R
    Gan To Kagaku Ryoho; 1986 Jun; 13(6):2123-7. PubMed ID: 3013099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination chemotherapy for non-small cell bronchogenic carcinoma with bleomycin, doxorubicin, methotrexate, and cis-dichlorodiammineplatinum(II) (BAMP).
    Vogl SE; Wollner D; Kaplan BH; Berenzweig M
    Cancer Treat Rep; 1980; 64(4-5):717-9. PubMed ID: 6159081
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment of non-small cell bronchopulmonary carcinoma with the combination of cyclophosphamide, adriamycin and cisplatin].
    Donnay Candil O; Jiménez Berlana U
    Rev Esp Oncol; 1983; 30(4):603-10. PubMed ID: 6100970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclophosphamide, doxorubicin, and cisplatin in the treatment of non-small cell bronchogenic carcinoma.
    Evans WK; Feld R; DeBoer G; Osoba D; Curtis JE; Baker MA; Myers RE; Quirt IC; Pritchard KI; Brown TC; Kutas GJ; Blackstein ME; Ottema B; Millband L
    Cancer Treat Rep; 1981; 65(11-12):947-54. PubMed ID: 7028256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of VP-16-213, cyclophosphamide, doxorubicin, and cisplatin (V-CAP) in advanced large cell lung cancer.
    Eagan RT; Frytak S; Nichols WC; Ingle JN; Creagan ET; Kvols LK; Coles DT
    Cancer Treat Rep; 1981; 65(7-8):715-7. PubMed ID: 6166376
    [No Abstract]   [Full Text] [Related]  

  • 35. [Bronchial arterial infusion chemotherapy with or without radiotherapy for advanced lung cancer].
    Huang DP
    Zhonghua Zhong Liu Za Zhi; 1990 May; 12(3):216-8. PubMed ID: 2249598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CAMP (cyclophosphamide, doxorubicin, methotrexate, and procarbazine) for epidermoid and large cell anaplastic carcinoma of the lung.
    Cambareri RJ; Smith FP; Macdonald JS; Haidak DJ; Ueno WM; Hoth DH; Woolley PV; Schein PS
    Cancer Treat Rep; 1981; 65(3-4):317-20. PubMed ID: 6263471
    [No Abstract]   [Full Text] [Related]  

  • 37. [Combination chemotherapy for bronchogenic carcinoma based on cell type].
    Ohta M; Hara N; Ichikawa Y; Kanda T; Shima K; Hokama M
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):86-94. PubMed ID: 2417564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase II evaluation of chlorozotocin in patients with non-small cell carcinoma of the lung.
    Casper ES; Gralla RJ
    Cancer Treat Rep; 1979 Apr; 63(4):549-50. PubMed ID: 156068
    [No Abstract]   [Full Text] [Related]  

  • 39. Phase II study of cis-diamminedichloroplatinum in patients with non-small cell lung cancer.
    Fujita J; Saijo N; Eguchi K; Shimizu E; Shinkai T; Tominaga K; Sasaki Y; Futami H; Sakurai M; Hoshi A
    Jpn J Cancer Res; 1985 May; 76(5):420-3. PubMed ID: 3924714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. cis-Dichlorodiammineplatinum(II) in the treatment of gynecologic malignancies: phase II trials by the Gynecologic Oncology Group.
    Thigpen T; Shingleton H; Homesley H; LaGasse L; Blessing J
    Cancer Treat Rep; 1979; 63(9-10):1549-55. PubMed ID: 498154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.